Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that were associated with various clinical presentations of COVID-19 using scRNA-seq technology coupled with a deep and compreh...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 812514
Main Authors Wang, Xiaorui, Bai, Han, Ma, Junpeng, Qin, Hongyu, Zeng, Qiqi, Hu, Fang, Jiang, Tingting, Mao, Weikang, Zhao, Yang, Chen, Xiaobei, Qi, Xin, Li, Mengyang, Xu, Jiao, Hao, Jingcan, Wang, Yankui, Ding, Xi, Liu, Yuanrui, Huang, Tianlong, Fang, Chao, Ge, Changli, Li, Dong, Hu, Ke, Ren, Xianwen, Zhang, Baojun, Zhang, Binghong, Shi, Bingyin, Zhang, Chengsheng
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that were associated with various clinical presentations of COVID-19 using scRNA-seq technology coupled with a deep and comprehensive analysis of unique cell surface markers and differentially expressed genes. We revealed that (TRAV1-2 + CD8 + )MAIT cells and (NCAM1 hi CD160 + )NK cells significantly enriched in the asymptomatic subjects whereas (LAG3 + CD160 + CD8 + )NKT cells increased in the symptomatic patients. We also observed that (CD68 - CSF1R - IL1B hi CD14 + )classical monocytes were positively correlated with the disease severity. Moreover, (CD33 - HLA-DMA - CD14 + )classical monocytes and (CLEC10A - S100A9 lo )pDC were associated with the viral persistence. The GO and KEGG analyses identified enriched pathways related to immune responses, inflammation, and apoptosis. These findings may enhance our understanding of the immunopathogenesis of COVID-19 and help develop novel strategies against SARS-CoV-2 infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Tram Pham, Montreal Clinical Research Institute (IRCM), Canada
Lead Contact
Reviewed by: James E. Thaventhiran, University of Cambridge, United Kingdom; Martina Severa, National Institute of Health (ISS), Italy
These authors have contributed equally to this work and share the first authorship
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.812514